why do we need cryptocurrency, Featured

American natural gas futures fell more than 3.00% in the day and are now reported at $3.351/million British heat.Tesla rose 2.5% and will launch the advanced intelligent summoning ASS function. Tesla (TSLA.US) rose 2.5% in intraday trading to $428.8. Tesla China official website launched a brand-new car function today-Actually Smart Summon. This function is suitable for Tesla vehicles with EAP (enhanced automatic driving assistance function) or FSD (full automatic driving capability). Tesla owners can automatically park the vehicle from the parking space and drive to the owner's side or the location designated by the owner on the mobile phone by operating on the Tesla application of the mobile phone, and the vehicle needs to be kept within the owner's sight during the moving process. It is reported that this function will be pushed to the owner through OTA remote software update function.USD/CAD of USD/CAD once rose by 0.2%, hitting a four-and-a-half-year high of 1.4244.

Jiaying Pharmaceutical Co., Ltd.: The chairman of the board proposed to buy back the company's shares of no more than 132.3 million yuan. On the evening of December 13, Jiaying Pharmaceutical announced that Li Neng, the chairman of the company, proposed that the company buy back some RMB common shares (A shares) issued by the company through the trading system of Shenzhen Stock Exchange with its own funds, and the repurchased shares are intended to be used for implementing employee stock ownership plan or equity incentive. According to the proposal, combined with the company's financial operation and actual situation, the number of shares to be repurchased this time is not less than 7 million shares (inclusive), accounting for about 1.3793% of the company's total share capital; It does not exceed 13.5 million shares (inclusive), accounting for about 2.6600% of the company's total share capital. According to the calculation that the maximum number of repurchased shares is 13.5 million shares (inclusive) and the maximum price of repurchased shares is 9.80 yuan/share (inclusive), the total amount of repurchased shares does not exceed 132.3 million yuan (inclusive).This week, the Shenzhen Stock Exchange took self-regulatory measures against 171 abnormal securities trading behaviors, and the Shenzhen Stock Exchange released regulatory trends: 1. Regulatory trends of listed companies (December 6-December 12, 2024) From December 6 to December 12, the Exchange took disciplinary action against one violation, involving information disclosure and standardized operation violations; Supervision letters were issued for 9 violations, 3 related to information disclosure and standardized operation violations, and 6 related to securities trading violations. This week, 18 inquiry letters and 5 other letters were sent out. II. Market Trading Supervision Dynamics (December 9-December 13, 2024) From December 9 to December 13, the Exchange took self-regulatory measures against 171 abnormal securities trading behaviors, involving abnormal trading situations such as intraday bidding, false declaration, etc. Focus on monitoring "*ST Tongzhou" with abnormal stock price fluctuation recently; A total of 9 major events of listed companies were verified, and 3 clues of suspected illegal cases were reported to the CSRC. (Issued by Shenzhen Stock Exchange)Jiaying Pharmaceutical Co., Ltd.: It plans to buy back 7 million to 13.5 million shares. Jiaying Pharmaceutical announced that it plans to use its own funds to buy back some issued RMB common shares (A shares) by centralized bidding for the implementation of employee stock ownership plan or equity incentive. The price of repurchased shares is not higher than 9.80 yuan/share (inclusive), and the number of shares to be repurchased is not less than 7 million shares (inclusive), accounting for about 1.3793% of the company's total share capital; And no more than 13.5 million shares (inclusive), accounting for about 2.6600% of the company's total share capital. The repurchase period is within 12 months from the date when the company's board of directors deliberated and approved the share repurchase plan.

Mckinsey agreed to pay $650 million to settle the criminal investigation of opioids by the U.S. Department of Justice. Mckinsey submitted a five-year deferred prosecution agreement to the federal court in Abingdon, Virginia, and agreed to pay $650 million to settle the criminal investigation of the U.S. Department of Justice on its work in guiding the opioid manufacturer Purdue Pharmaceutical to increase sales. According to court documents, Martin Elling, a former senior partner of McKinsey, agreed to plead guilty to obstruction of justice because he destroyed McKinsey's consulting records for Purdue Pharmaceutical. He will plead guilty on January 10th next year. Mckinsey has previously reached various settlement agreements totaling nearly $1 billion. The company had previously faced lawsuits in several States in the United States, and was accused of providing sales analysis and marketing advice to pharmaceutical companies such as Purdue Pharmaceutical and Johnson & Johnson, which contributed to the popularity of opioids.UBS raised the target price of Broadcom from $200 to $220.Wal-Mart Mexico's share price rose more than 4% after the regulator ruled that it was involved in monopolistic behavior.